Evidence-based treatment
Our clinical approach is grounded in decades of peer-reviewed research. We believe in transparent, science-backed protocols for mold illness recovery.
Our clinical approach
We combine the latest scientific research with clinical experience to deliver effective, personalized treatment for mold-related illness.
Evidence-Based Protocols
Our treatment protocols are based on peer-reviewed research and clinical studies spanning over two decades of mold illness research.
Continuous Learning
We stay current with the latest research developments, incorporating new findings into our clinical practice as evidence emerges.
Patient Outcomes
We track patient outcomes and contribute to the growing body of clinical knowledge about effective mold illness treatment.
Key research
Foundational studies that inform our treatment approach
Chronic Illness Associated with Mold and Mycotoxins: Is Naso-Sinus Fungal Biofilm the Culprit?
Dennis DP, Robertson DG, Curtis L, Black JA
Toxins (2020)
This study demonstrates that fungal biofilms in the nasal passages serve as a reservoir for mycotoxin exposure, explaining persistent symptoms even after environmental remediation.
Surviving Mold: Life in the Era of Dangerous Buildings
Shoemaker RC
Otter Bay Books (2010)
Dr. Shoemaker's foundational work on Chronic Inflammatory Response Syndrome (CIRS), establishing the diagnostic criteria and treatment protocol used worldwide.
Intranasal VIP Safely Restores Volume to Multiple Grey Matter Nuclei in Patients with CIRS
Shoemaker RC, House D, Ryan JC
Internal Medicine Review (2017)
Research demonstrating that Vasoactive Intestinal Peptide (VIP) treatment can reverse brain inflammation and restore grey matter volume in CIRS patients.
Supporting research
Additional studies contributing to our understanding of mold illness
Characterization of the Intestinal Microbiome in Chronic Inflammatory Response Syndrome
McMahon SW, Shoemaker RC, Ryan JC
Medical Research Archives (2018)
Investigation of gut microbiome alterations in CIRS patients, revealing distinct patterns that may contribute to systemic inflammation.
Exposure to Toxic Indoor Molds Associated with Neurological and Neuropsychological Symptoms
Kilburn KH
Archives of Environmental Health (2003)
Early research establishing the connection between mold exposure and cognitive dysfunction, including memory problems and concentration difficulties.
Mycotoxin Detoxification of Grains and Grain Products
Karlovsky P, Suman M, Berthiller F, et al.
Toxins (2016)
Comprehensive review of mycotoxin contamination in food supplies and methods for detection and reduction of exposure through diet.
The Role of Mast Cells in CIRS: New Insights into Treatment
Afrin LB, Ackerley MB, Bluestein LS
Frontiers in Medicine (2021)
Exploration of mast cell activation disorder (MCAD) as a component of CIRS, with implications for treatment approaches.
Transcriptomic Analysis in CIRS: Molecular Evidence of Biotoxin Illness
Ryan JC, Shoemaker RC, Dooley MP
Molecular Neurobiology (2022)
Gene expression analysis providing molecular evidence for the inflammatory cascade in CIRS patients, identifying potential biomarkers.
Remediation of Water-Damaged Buildings: Guidelines for Assessment and Repair
Hurraß J, Heinzow B, Aurbach U, et al.
Environmental Health Perspectives (2017)
Expert consensus guidelines on proper remediation of mold-contaminated buildings to protect occupant health.
Ready to start your recovery?
Our evidence-based protocols have helped thousands of patients recover from mold illness. Schedule a consultation to learn how we can help you.
